Delivery Order SPE2DB22D3501-SPE2DB26FTJ28
- Not listed
- The Defense Logistics Agency has awarded a delivery order valued at $4,143.96 to AmerisourceBergen Drug Corp for the supply of Lisdexamfetamine 50 mg capsules (100 count). This competitively awarded, firm fixed-price contract was issued on November 5, 2025, with an ultimate completion date of November 6, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a $2,681.68 delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Lisdexamfetamine 30 mg capsules in quantities of 100 units. This is a firm fixed price contract with an ultimate completion date of September 12, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract was competitively awarded with no set-aside designation and will...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of Lisdexamfetamine 30 mg capsules (100 count) with a ceiling value of $1,181.21. This is a firm fixed price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is scheduled for completion by November 10, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,846.19 to AmerisourceBergen Drug Corp for the supply of Lisdexamfetamine 30 mg capsules (90-count units) with a firm fixed price structure. The award was made on November 14, 2025, with an ultimate completion date of November 17, 2025, and represents a non-competitive, non-set-aside delivery order. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, executed this...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,443.55 to AmerisourceBergen Drug Corp for the supply of Lisdexamfetamine 40 mg capsules (100 count) on November 6, 2025, with an ultimate completion date of November 7, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Lisdexamfetamine 30 mg capsules (100-count) with a ceiling value of $1,257.88. This competitively awarded, firm fixed-price delivery order is set to be completed by November 18, 2025, and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Lisdexamfetamine 40 mg capsules (100 count) valued at $3,771.21. This is a firm fixed-price delivery order with an ultimate completion date of November 5, 2025, and represents a competitively awarded, non-set-aside contract. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lisdexamfetamine 20 mg capsules (100-count) with a ceiling value of $5,176.58 under a firm fixed-price contract type. The award was made on October 30, 2025, with an ultimate completion date of October 31, 2025, and no set-aside designation was utilized. The pharmaceutical products will be delivered to the Conshohocken, Pennsylvania location. This delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Lisdexamfetamine 60 mg capsules (90-count units) valued at $2,794.14 under a firm fixed-price contract type. This non-set-aside award represents a child delivery order executed against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement running through December 2026. The product will...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lisdexamfetamine 40 mg capsules (100 count) with a ceiling value of $2,457.75. This is a firm fixed-price delivery order with no set-aside designation, issued on November 14, 2025, and scheduled for completion by November 17, 2025. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract action under...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB26FTJ28Delivery Order
The Defense Logistics Agency (DLA) awarded a $2,681.36 firm fixed price delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Lisdexamfetamine 50 mg capsules (90-count units). This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through December 2026. The delivery order is scheduled for completion by November 4, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is one of the federal government's primary pharmaceutical distributors, serving military and veteran healthcare systems through its extensive portfolio of brand-name and generic medications, vaccines, and medical supplies. The company's competitively awarded contracts with DLA demonstrate its capability to fulfill diverse federal medical procurement requirements across multiple therapeutic domains, ranging from small-value transactions to orders exceeding $45,000. This delivery order for Lisdexamfetamine, a medication commonly prescribed for attention deficit hyperactivity disorder, exemplifies the company's role in supporting the Defense Health Agency and other federal healthcare systems with critical pharmaceutical commodities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 11/3/25 |